XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock
Capital Surplus [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Deferred Benefits for Directors [Member]
Beginning Balance at Dec. 31, 2021 $ 2,693,166 $ 144,484 $ 141,834 $ 1,635,642 $ 977,765 $ (199,759) $ (5,120) $ (1,680)
Beginning Balance, shares at Dec. 31, 2021     62,307,245          
Net income 139,903       139,903      
Other comprehensive loss (261,520)           (261,520)  
Comprehensive income (loss) (121,617)              
Common dividends declared (60,750)       (60,750)      
Preferred dividends declared (7,594)       (7,594)      
Stock issued for dividend reinvestment         (792) 792    
Stock issued for dividend reinvestment, shares     23,478          
Treasury shares acquired (113,600)         (113,600)    
Treasury shares acquired, shares     (3,250,383)          
Stock options exercised 1,629     (384)   2,013    
Stock options exercised, shares     59,959          
Restricted stock granted       (5,521)   5,521    
Restricted stock granted, shares     164,206          
Stock compensation expense 4,519     4,519        
Deferred benefits for directors- net (101)     24       (125)
Ending Balance at Sep. 30, 2022 2,395,652 144,484 $ 141,834 1,634,280 1,048,532 (305,033) (266,640) (1,805)
Ending Balance, shares at Sep. 30, 2022     59,304,505          
Beginning Balance at Jun. 30, 2022 2,467,951 144,484 $ 141,834 1,632,617 1,018,209 (291,337) (176,061) (1,795)
Beginning Balance, shares at Jun. 30, 2022     59,698,788          
Net income 53,033       53,033      
Other comprehensive loss (90,579)           (90,579)  
Comprehensive income (loss) (37,546)              
Common dividends declared (20,024)       (20,024)      
Preferred dividends declared (2,531)       (2,531)      
Stock issued for dividend reinvestment         (155) 155    
Stock issued for dividend reinvestment, shares     4,832          
Treasury shares acquired (14,180)         (14,180)    
Treasury shares acquired, shares     (409,340)          
Stock options exercised 251     (78)   329    
Stock options exercised, shares     10,225          
Stock compensation expense 1,727     1,727        
Deferred benefits for directors- net 4     14       (10)
Ending Balance at Sep. 30, 2022 2,395,652 144,484 $ 141,834 1,634,280 1,048,532 (305,033) (266,640) (1,805)
Ending Balance, shares at Sep. 30, 2022     59,304,505          
Beginning Balance at Dec. 31, 2022 2,426,662 144,484 $ 141,834 1,635,877 1,077,675 (308,964) (262,416) (1,828)
Beginning Balance, shares at Dec. 31, 2022     59,198,963          
Net income 124,064       124,064      
Other comprehensive loss (35,490)           (35,490)  
Comprehensive income (loss) 88,574              
Common dividends declared (61,729)       (61,729)      
Preferred dividends declared (7,594)       (7,594)      
Stock issued for dividend reinvestment         (819) 819    
Stock issued for dividend reinvestment, shares     22,455          
Treasury shares acquired (3,745)         (3,745)    
Treasury shares acquired, shares     (162,432)          
Stock options exercised 146     (60)   206    
Stock options exercised, shares     6,432          
Restricted stock granted       (8,260)   8,260    
Restricted stock granted, shares     299,278          
Stock compensation expense 5,806     5,806        
Deferred benefits for directors- net (179)     32       (211)
Ending Balance at Sep. 30, 2023 2,447,941 144,484 $ 141,834 1,633,395 1,131,597 (303,424) (297,906) (2,039)
Ending Balance, shares at Sep. 30, 2023     59,364,696          
Beginning Balance at Jun. 30, 2023 2,464,998 144,484 $ 141,834 1,630,963 1,118,135 (303,770) (264,627) (2,021)
Beginning Balance, shares at Jun. 30, 2023     59,355,062          
Net income 36,842       36,842      
Other comprehensive loss (33,279)           (33,279)  
Comprehensive income (loss) 3,563              
Common dividends declared (20,583)       (20,583)      
Preferred dividends declared (2,531)       (2,531)      
Stock issued for dividend reinvestment         (266) 266    
Stock issued for dividend reinvestment, shares     7,275          
Stock options exercised 24     (14)   38    
Stock options exercised, shares     941          
Restricted stock granted       (42)   42    
Restricted stock granted, shares     1,418          
Stock compensation expense 2,472     2,472        
Deferred benefits for directors- net (2)     16       (18)
Ending Balance at Sep. 30, 2023 $ 2,447,941 $ 144,484 $ 141,834 $ 1,633,395 $ 1,131,597 $ (303,424) $ (297,906) $ (2,039)
Ending Balance, shares at Sep. 30, 2023     59,364,696